New product intros.
D000068879:Adalimumab; D000077944:Alefacept; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068180:Aripiprazole; D006801:Humans; D004364:Pharmaceutical Preparations; D010879:Piperazines / Q000627:therapeutic use; D015363:Quinolones / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004364:Pharmaceutical Preparations; D010879:Piperazines; D015363:Quinolones; D011993:Recombinant Fusion Proteins; D000068180:Aripiprazole; D000077944:Alefacept; D000068879:Adalimumab